BioMed Realty Trust, Inc. · San Diego, CA United States ·(NYSE: BMR)

BioMed Realty knows its niche. A self-administered real estate investment trust (REIT), the company acquires, develops, leases, and manages research laboratories and offices for biotechnology companies, pharmaceutical firms, research institutions, and other life science tenants. BioMed owns more than 65 properties in about a dozen states; they contain more than 100 buildings and total approximately 12 million sq. ft. of rentable space. The REIT's preferred markets include research and development hubs such as Boston, New York, San Diego, San Francisco, and Seattle. Its largest tenants include Human Genome Sciences (20% of sales), Vertex Pharmaceuticals, Genzyme, and Centocor. To read the full description, subscribe now.